Zero order controlled drug delivery system

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050106251A1
SERIAL NO

10484748

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A controlled release dosage form comprising: (i) a tablet core comprising a pharmaceutically active ingredient and one or more pharmaceutically acceptable matrix forming polymers, (ii) a substantially insoluble casing extended over the tablet core covering between 25 to 99% of the surface area of the tablet core, like for example covering only the major surfaces like in FIG. 1 or on major surface and the sidewells like in FIG. 2, the casing resulting from electrostatic deposition of a powder comprising fusible particles onto the tablet core and fusing the particles to form a thin film such that the said electrostatic coated tablet releases the active ingredient with a release profile of active ingredient for 0 to at least 50% by weight release of active ingredient defined by the equations y=k*t.sup.n in which y is the fraction of active ingredient released, k is the kinetic constant, t is time, n is the release exponent and n is the range 0.70 to 1.0 i.e. an approximately zero order release profile.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXO GROUP LIMITEDBERKELEY AVENUE GREENFORD MIDDLESEX UB6 0NN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Langridge, John Richard Sint Oedeurode, NL 12 89
Lawal, Olayinka Dartford, GB 1 3
Tian, Wei Little Mellon, GB 182 1358

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation